Immunome Inc. held its 2023 Annual Meeting of Stockholders, where Class III directors were elected, an amendment to the company's Certificate of Incorporation was not approved, and the selection of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2023 was ratified.